Permits for the import of unregistered drugs are planned to be issued for a year
The Ministry of Health of the Russian Federation proposed to set the period of validity of the permit for the import of unregistered drugs into the country for one year. The relevant document is posted on the regulatory legal acts portal.
Registered and (or) unregistered medicines intended for clinical trials have become an exception in this draft resolution. In addition, it does not include opinions on drugs for the Foundation for the Support of Children with Severe Life-threatening and Chronic Illnesses, including Circle of Kindness rare diseases.
The amendments should come into force on March 1, 2023.
Earlier, Aleksey Kedrin, Chairman of the Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, listed the measures of the Russian government introduced to reduce the risk of drug shortages in the Russian Federation.
Rate the material